当前位置：首页 > 文献互助 > 互助详情

The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha复制

用户zCL_XFDWAdZs 2小时前 24 10 已关闭

DOI: 10.1183/13993003.congress-2018.pa1047复制

文献链接: https://publications.ersnet.org/lookup/doi/10.1183/13993003.congress-2018.PA1047复制

其他信息:

出版社: European Respiratory Society
作者: Gabriele Matschiner; Song Huang; Samuel Constant; Barbara Rattenstetter; Hendrik Gille; Andreas M Hohlbaum; Beverly Koller; David Keeling; Mary Fitzgerald

上一篇：Hyperpigmentation and ACTH – an overview of literature

下一篇：The Direct Conversion of Esters to Ketones Enabled by a Traceless Activating Group

互助时间线

2025-08-11 14:25:21 [关闭求助]

系统关闭了求助

备注: 显示free已经是全文了 没有下载选项 直接看网页哦

2025-08-11 13:08:00 [发起求助]

最新发布的求助

POS0536 SAFETY, PHARMACOKINETICS, BIOMARKER, AND EFFICACY OF E6742, A DUAL ANTAGONIST OF TOLL-LIKE RECEPTOR 7 AND 8, IN A FIRST-IN-PATIENT PHASE1/2 STUDY IN SYSTEMIC LUPUS ERYTHEMATOSUS 13分钟前
A review of prednicarbate (Dermatop) 20分钟前
Clinical, tumor and product features associated with outcomes after axicabtagene ciloleucel therapy in follicular lymphoma 38分钟前
Late asthmatic reactions to inhalation of fractions from extracts of Candida albicans and Asperguillus fumigatus 1小时前
Treatment adherence rates across different psychiatric disorders and settings: findings from a large patient cohort 1小时前
The Direct Conversion of Esters to Ketones Enabled by a Traceless Activating Group 1小时前
The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha 2小时前
Hyperpigmentation and ACTH – an overview of literature 3小时前
Unravelling the potential of small molecule tumor necrosis factor-α (TNF) inhibitors: A comprehensive review 4小时前
Advances in locally administered nucleic acid therapeutics 4小时前
{Appendices}[Appendix I](Appendix I A. General Reagents) Copper(ii) Chloride - british pharmacopoeia[1739367358.54831.html] 4小时前
Rituximab therapy for membranous nephropathy: a systematic review 4小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com